Home/Filings/4/0001104659-23-073331
4//SEC Filing

Naor Nir 4

Accession 0001104659-23-073331

CIK 0001137883other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:06 PM ET

Size

5.5 KB

Accession

0001104659-23-073331

Insider Transaction Report

Form 4
Period: 2023-06-19
Naor Nir
Director
Transactions
  • Award

    Common Stock

    2023-06-19+11,99911,999 total
Footnotes (1)
  • [F1]Shares acquired are shares of restricted stock awarded on June 19, 2023 pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on June 19, 2023 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director (and committee member, as applicable) of Brainstorm Cell Therapeutics Inc. on each vesting date.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001982278

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:06 PM ET
Size
5.5 KB